COX-2 is a novel target in therapy of mycosis fungoides

Leukemia

Volumn 24, Issue 12, 2010, Pages 2127-2129

  Kopp, K L M ^a   Dabelsteen, S ^a   Krejsgaard, T ^a   Eriksen, K W ^a   Geisler, C ^a   Becker, J C ^b   Wasik, M ^c   Odum, N ^a   Woetmann, A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; JANUS KINASE; PROSTAGLANDIN; PROSTAGLANDIN E; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; PROTEIN C FOS; PROTEIN C JUN; STAT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER INHIBITION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; LETTER; MOLECULARLY TARGETED THERAPY; MOUSE; MYCOSIS FUNGOIDES; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

EID: 78650305973     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.221     Document Type: Letter

References (8)

1. Diamandidou E, Cohen PR, Kurzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996; 88: 2385-2409.
2. Prince HM, Whittaker S, Hoppe RT. How I treat mycosis fungoides and Sézary syndrome. Blood 2009; 114: 4337-4353.
3. Hwang ST, Janik JE, Jaffe ES, Wilson WH. Mycosis fungoides and Sézary syndrome. Lancet 2009; 371: 945-957.
4. Kopp KLM, Kauczok CS, Lauenborg B, Krejsgaard T, Eriksen KW, Zhang Q et al. COX-2-dependent PGE2 acts as growth factor in mycosis fungoides (MF). Leukemia 2010; 24: 1179-1185.
5. Harris RE. Cyclooxygenase-2 (COX-2) and the inflammogenesis of cancer. Subcell Biochem 2007; 42: 93-126.
6. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C et al. The COX-2/PGE2 pathway: keyroles in the hallmarks of cancer and adaptation to the tumor microenvironment. Carcinogenesis 2009; 30: 377-386.
7. Krejsgaard T, Kopp K, Ralfkiaer E, Willumsgaard AE, Eriksen KW, Labuda T et al. A novel xenograft model of cutaneous T-cell lymphoma. Exp Dermatol 2010. doi:10.1111/j.1600-0625. 2010.01138.x.
8. Harris RE. Cyclooxygenase-2 (COX-2) blockade in the chemo-prevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 2009; 17: 55-67.